{
  "resourceType" : "MedicinalProductDefinition",
  "id" : "Triogen-250mg-Capsule",
  "meta" : {
    "profile" : ["http://fhir.ch/ig/ch-epl/StructureDefinition/ch-idmp-medicinalproductdefinition"]
  },
  "text" : {
    "status" : "extensions",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: MedicinalProductDefinition Triogen-250mg-Capsule</b></p><a name=\"Triogen-250mg-Capsule\"> </a><a name=\"hcTriogen-250mg-Capsule\"> </a><div style=\"display: inline-block; background-color: #d9e0e7; padding: 6px; margin: 4px; border: 1px solid #8da1b4; border-radius: 5px; line-height: 60%\"><p style=\"margin-bottom: 0px\"/><p style=\"margin-bottom: 0px\">Profile: <a href=\"StructureDefinition-ch-idmp-medicinalproductdefinition.html\">IDMP MedicinalProductDefinition</a></p></div><p><b>CH - SMC Authorized Dose Form</b>: <span title=\"Codes:{http://standardterms.edqm.eu 10210000}\">Capsule, hard</span></p><p><b>CH - EPL Full Limitation Text</b>: TRIOGEN wird verg端tet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und 端berwacht werden.</p><p><b>identifier</b>: <a href=\"NamingSystem-MPID.html\" title=\"Temporary Identifier in this implementation guide until officially released by Swissmedic\">Medical Product Identifier</a>/CH-7601001403062-6743101</p><p><b>indication</b>: </p><div><p>Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.</p>\n</div><p><b>legalStatusOfSupply</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply 756005022003}\">Medicinal product subject to medical or veterinary prescription (B)</span></p><p><b>additionalMonitoringIndicator</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator 756005001003}\">No Warning</span></p><p><b>pediatricUseIndicator</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator 756005003001}\">Authorised for the treatment in children</span></p><p><b>classification</b>: <span title=\"Codes:{http://www.whocc.no/atc A16AX12}\">trientine</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category 756005021001}\">NA KAS art. 12 para. 5 TPLO</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode 756005004001}\">Synthetic</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type 756001003002}\">Originator product</span>, <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus 070000}, {http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus 079900}\">07. STOFFWECHSEL</span></p><p><b>attachedDocument</b>: </p><ul><li><a href=\"DocumentReference-DocRef-FI-Triogen.html\">DocumentReference: identifier = http://fhir.ch/ig/ch-epl/sid/attno#Application / Assessment Tracking Number#123456789-initial submission-Example-qrs-123; status = current; type = Fachinformation; date = 2019-12-01 00:00:00+0000</a></li><li><a href=\"DocumentReference-DocRef-PI-Triogen.html\">DocumentReference: identifier = http://fhir.ch/ig/ch-epl/sid/attno#Application / Assessment Tracking Number#123456789-initial submission-Example-qrs-321; status = current; type = Patienteninformation; date = 2019-12-01 00:00:00+0000</a></li></ul><blockquote><p><b>name</b></p><p><b>productName</b>: Triogen 250 mg, Kapseln</p><p><b>type</b>: <span title=\"Codes:{http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type SMC}\">Zugelassener Arzneimittelname</span></p><h3>Usages</h3><table class=\"grid\"><tr><td style=\"display: none\">-</td><td><b>Country</b></td><td><b>Language</b></td></tr><tr><td style=\"display: none\">*</td><td><span title=\"Codes:{urn:iso:std:iso:3166 CH}\">Switzerland</span></td><td><span title=\"Codes:{urn:ietf:bcp:47 de-CH}\">German (Switzerland)</span></td></tr></table></blockquote></div>"
  },
  "extension" : [{
    "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/authorizedDoseForm",
    "valueCodeableConcept" : {
      "coding" : [{
        "system" : "http://standardterms.edqm.eu",
        "code" : "10210000",
        "display" : "Capsule, hard"
      }]
    }
  },
  {
    "url" : "http://fhir.ch/ig/ch-epl/StructureDefinition/fullLimitationText",
    "valueString" : "TRIOGEN wird verg端tet zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen. Die Behandlung muss von Gastroenterologen oder Hepatologen mit Erfahrung bei der Behandlung von Patienten mit Morbus Wilson initiiert und 端berwacht werden."
  }],
  "identifier" : [{
    "system" : "http://fhir.ch/ig/ch-epl/sid/mpid",
    "value" : "CH-7601001403062-6743101"
  }],
  "indication" : "Zur Behandlung der Kupferspeicherkrankheit (Morbus Wilson) bei Patienten, die eine Behandlung mit D-Penicillamin nicht vertragen.",
  "legalStatusOfSupply" : {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-legal-status-of-supply",
      "code" : "756005022003",
      "display" : "Medicinal product subject to medical or veterinary prescription (B)"
    }]
  },
  "additionalMonitoringIndicator" : {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-additional-monitoring-indicator",
      "code" : "756005001003",
      "display" : "No Warning"
    }]
  },
  "pediatricUseIndicator" : {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-pediatric-use-indicator",
      "code" : "756005003001",
      "display" : "Authorised for the treatment in children"
    }]
  },
  "classification" : [{
    "coding" : [{
      "system" : "http://www.whocc.no/atc",
      "code" : "A16AX12"
    }]
  },
  {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-authorisation-category",
      "code" : "756005021001",
      "display" : "NA KAS art. 12 para. 5 TPLO"
    }]
  },
  {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-SMC-therapeuticproductcode",
      "code" : "756005004001",
      "display" : "Synthetic"
    }]
  },
  {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-product-type",
      "code" : "756001003002",
      "display" : "Originator product"
    }]
  },
  {
    "coding" : [{
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus",
      "code" : "070000",
      "display" : "07. STOFFWECHSEL"
    },
    {
      "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-epl-foph-index-therapeuticus",
      "code" : "079900",
      "display" : "07.99. Varia"
    }]
  }],
  "attachedDocument" : [{
    "reference" : "DocumentReference/DocRef-FI-Triogen"
  },
  {
    "reference" : "DocumentReference/DocRef-PI-Triogen"
  }],
  "name" : [{
    "productName" : "Triogen 250 mg, Kapseln",
    "type" : {
      "coding" : [{
        "system" : "http://fhir.ch/ig/ch-epl/CodeSystem/ch-medicinal-product-name-type",
        "code" : "SMC",
        "display" : "Zugelassener Arzneimittelname"
      }]
    },
    "usage" : [{
      "country" : {
        "coding" : [{
          "system" : "urn:iso:std:iso:3166",
          "code" : "CH",
          "display" : "Switzerland"
        }]
      },
      "language" : {
        "coding" : [{
          "system" : "urn:ietf:bcp:47",
          "code" : "de-CH",
          "display" : "German (Switzerland)"
        }]
      }
    }]
  }]
}